Aarti Pharmalabs Limited (AARTIPHARM) — Cash Flow Quality Index
Aarti Pharmalabs Limited (AARTIPHARM) has a Cash Flow Quality Index of 0.71x as of December 2023. Operating cash flow of Rs375.40 Million is below net income of Rs527.60 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how well can Aarti Pharmalabs Limited service its debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Aarti Pharmalabs Limited Cash Flow Quality Index (2022–2025)
Historical Cash Flow Quality Index for Aarti Pharmalabs Limited across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Aarti Pharmalabs Limited operating cash flow efficiency.
Annual Cash Flow Quality Index for Aarti Pharmalabs Limited (2022–2025)
Year-by-year earnings quality comparison for Aarti Pharmalabs Limited.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.22x | Rs3.32 Billion | Rs2.72 Billion | ▲ +22.0% |
| 2024 | 1.00x | Rs2.16 Billion | Rs2.17 Billion | ▼ -1.1% |
| 2023 | 1.01x | Rs2.63 Billion | Rs2.61 Billion | ▲ +458.6% |
| 2022 | -0.28x | Rs-437.04 Million | Rs1.55 Billion | — |